
Bfenac0.09%
Popular Pharmaceuticals Ltd.

Ophthalmic Solution
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID).
The mechanism of anti-inflammatory activity is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
Prostaglandins have been shown in many animal models to be mediators of certain kinds of intraocular inflammation.
In studies performed in animal eyes, prostaglandins have been shown to produce disruption of the blood-aqueous humor barrier, vasodilation, increased vascular permeability, leukocytosis and increased intraocular pressure.
| Condition | Dosage | Notes |
|---|---|---|
| Adults | 1 drop to the problem eye 2 times a day; treatment should start 24 hours after surgery and should continue for 2 weeksChildren: Use and dose must be determined by the doctor | |
| Pediatric Use | Safety and efficacy in pediatric patients below the age of 18 have not been established yet |
| Condition | Dosage | Notes |
|---|---|---|
| Adults | 1 drop to the problem eye 2 times a day; treatment should start 24 hours after surgery and should continue for 2 weeksChildren: Use and dose must be determined by the doctor | |
| Pediatric Use | Safety and efficacy in pediatric patients below the age of 18 have not been established yet |
What is Optifen 0.09% used for?
Bromfenac is indicated for the treatment of postoperative inflammation and the reduction of ocular pain in patients who have undergone cataract extraction
What is the dosage of Optifen 0.09%?
Adults: 1 drop to the problem eye 2 times a day; treatment should start 24 hours after surgery and should continue for 2 weeksChildren: Use and dose must be determined by the doctor.Pediatric Use: Safety and efficacy in pediatric patients below the age of 18 have not been established yet.
What are the side effects of Optifen 0.09%?
The most commonly reported adverse reactions following use of Bromfenac after cataract surgery include: abnormal sensation in eye, conjunctival hyperemia, eye irritation (including burning/stinging), eye pain, eye pruritus, eye redness, headache and iritis. These events were reported in 2-7% of patients
Who should not take Optifen 0.09%?
Bromfenac ophthalmic solution is contraindicated in patients with known hypersensitivity to any ingredients of the formulation.
What precautions should be taken with Optifen 0.09%?
All topical NSAIDs may slow or delay healing. Topical corticosteroids are also known to slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems. It is recommended that Bromfenac ophthalmic solution be used with caution in patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding ti…
Is Optifen 0.09% safe during pregnancy and breastfeeding?
Pregnancy Category C. This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when Bromfenac ophthalmic solution is administered to a nursing mother.
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.